Atherosclerotic cardiovascular disease is an inflammatory disorder and both MR studies and randomized controlled trials suggest that inhibition of IL‐6 signalling reduces risk of cardiovascular outcomes and thromboembolic events.16, 19. This evidence concerns the gene IL6 and cardiovascular disorder.